Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteogenesis | 59 | 2024 | 255 | 10.120 |
Why?
|
Cell Differentiation | 82 | 2022 | 1521 | 7.450 |
Why?
|
Growth Differentiation Factor 2 | 50 | 2022 | 151 | 7.450 |
Why?
|
Osteosarcoma | 24 | 2022 | 160 | 4.600 |
Why?
|
Cell Proliferation | 74 | 2024 | 1649 | 3.880 |
Why?
|
Growth Differentiation Factors | 19 | 2019 | 57 | 3.620 |
Why?
|
Stem Cells | 27 | 2022 | 372 | 3.520 |
Why?
|
Signal Transduction | 63 | 2024 | 3370 | 3.440 |
Why?
|
Adenoviridae | 29 | 2018 | 349 | 3.260 |
Why?
|
beta Catenin | 27 | 2022 | 266 | 3.160 |
Why?
|
Genetic Vectors | 22 | 2019 | 446 | 2.880 |
Why?
|
Wnt Proteins | 16 | 2017 | 130 | 2.800 |
Why?
|
Mice | 144 | 2024 | 11722 | 2.770 |
Why?
|
Tissue Scaffolds | 11 | 2019 | 111 | 2.760 |
Why?
|
Bone Morphogenetic Proteins | 22 | 2016 | 127 | 2.740 |
Why?
|
Osteoblasts | 16 | 2020 | 98 | 2.730 |
Why?
|
Bone Neoplasms | 18 | 2022 | 328 | 2.480 |
Why?
|
Wnt Signaling Pathway | 11 | 2022 | 97 | 2.410 |
Why?
|
MicroRNAs | 11 | 2023 | 550 | 2.310 |
Why?
|
Animals | 182 | 2024 | 27272 | 2.270 |
Why?
|
Mice, Nude | 45 | 2021 | 814 | 2.250 |
Why?
|
Cell Line, Tumor | 65 | 2024 | 2549 | 2.210 |
Why?
|
Cell Line | 59 | 2022 | 2494 | 2.120 |
Why?
|
HEK293 Cells | 38 | 2020 | 638 | 2.110 |
Why?
|
Hepatocytes | 14 | 2019 | 119 | 1.950 |
Why?
|
RNA, Long Noncoding | 8 | 2022 | 117 | 1.780 |
Why?
|
Gene Expression Regulation, Neoplastic | 28 | 2024 | 1265 | 1.670 |
Why?
|
Transduction, Genetic | 12 | 2017 | 160 | 1.620 |
Why?
|
Humans | 220 | 2024 | 88852 | 1.500 |
Why?
|
Gene Expression Regulation | 19 | 2020 | 1974 | 1.430 |
Why?
|
Apoptosis | 41 | 2023 | 1715 | 1.400 |
Why?
|
Craniosynostoses | 7 | 2023 | 77 | 1.380 |
Why?
|
Antineoplastic Agents | 16 | 2024 | 2410 | 1.350 |
Why?
|
Cell Movement | 28 | 2021 | 783 | 1.340 |
Why?
|
RNA, Small Interfering | 10 | 2019 | 557 | 1.320 |
Why?
|
S100 Proteins | 4 | 2015 | 51 | 1.320 |
Why?
|
Intercellular Signaling Peptides and Proteins | 6 | 2017 | 181 | 1.310 |
Why?
|
Receptors, Notch | 2 | 2019 | 123 | 1.270 |
Why?
|
Tissue Engineering | 5 | 2019 | 185 | 1.220 |
Why?
|
Bone and Bones | 9 | 2020 | 269 | 1.220 |
Why?
|
Cells, Cultured | 36 | 2024 | 2879 | 1.210 |
Why?
|
Gene Transfer Techniques | 8 | 2015 | 153 | 1.160 |
Why?
|
Bone Regeneration | 8 | 2023 | 59 | 1.140 |
Why?
|
STAT Transcription Factors | 2 | 2020 | 18 | 1.130 |
Why?
|
RNA Interference | 11 | 2021 | 376 | 1.100 |
Why?
|
Panax | 15 | 2017 | 170 | 1.090 |
Why?
|
Trans-Activators | 11 | 2005 | 443 | 1.090 |
Why?
|
Cytoskeletal Proteins | 10 | 2005 | 228 | 1.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2018 | 27 | 1.040 |
Why?
|
Neoplasms | 12 | 2024 | 3020 | 1.030 |
Why?
|
Monensin | 3 | 2023 | 16 | 1.020 |
Why?
|
Cranial Sutures | 5 | 2020 | 47 | 1.020 |
Why?
|
Transfection | 17 | 2021 | 911 | 1.010 |
Why?
|
Colorectal Neoplasms | 25 | 2023 | 980 | 1.010 |
Why?
|
Protein-Tyrosine Kinases | 9 | 2013 | 307 | 0.990 |
Why?
|
Cell Cycle Proteins | 5 | 2015 | 401 | 0.990 |
Why?
|
Neovascularization, Pathologic | 4 | 2022 | 363 | 0.990 |
Why?
|
Liver | 9 | 2019 | 1204 | 0.980 |
Why?
|
Fibroblasts | 8 | 2018 | 755 | 0.980 |
Why?
|
Bone Morphogenetic Protein 2 | 7 | 2017 | 48 | 0.960 |
Why?
|
Antigens, Polyomavirus Transforming | 4 | 2018 | 47 | 0.950 |
Why?
|
Gene Expression | 16 | 2019 | 1309 | 0.930 |
Why?
|
Transcription Factors | 10 | 2024 | 1650 | 0.920 |
Why?
|
Up-Regulation | 19 | 2021 | 727 | 0.870 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 103 | 0.860 |
Why?
|
Hydrogels | 2 | 2024 | 86 | 0.860 |
Why?
|
Adipogenesis | 5 | 2021 | 39 | 0.860 |
Why?
|
Pyrvinium Compounds | 1 | 2022 | 5 | 0.850 |
Why?
|
Ossification, Heterotopic | 3 | 2021 | 33 | 0.840 |
Why?
|
Ginsenosides | 12 | 2016 | 123 | 0.830 |
Why?
|
Genetic Engineering | 2 | 2017 | 115 | 0.830 |
Why?
|
Xenograft Model Antitumor Assays | 17 | 2024 | 470 | 0.830 |
Why?
|
Wnt3A Protein | 6 | 2015 | 23 | 0.800 |
Why?
|
Drugs, Chinese Herbal | 6 | 2017 | 67 | 0.790 |
Why?
|
Sapogenins | 4 | 2015 | 24 | 0.790 |
Why?
|
Tretinoin | 8 | 2015 | 128 | 0.770 |
Why?
|
Viral Proteins | 4 | 2017 | 300 | 0.770 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 20 | 2022 | 887 | 0.740 |
Why?
|
Leptin | 2 | 2020 | 102 | 0.720 |
Why?
|
Plant Extracts | 13 | 2017 | 244 | 0.720 |
Why?
|
Neoplasm Metastasis | 13 | 2022 | 1107 | 0.720 |
Why?
|
Janus Kinases | 1 | 2020 | 23 | 0.710 |
Why?
|
Antineoplastic Agents, Phytogenic | 11 | 2016 | 277 | 0.700 |
Why?
|
Cell Division | 13 | 2014 | 696 | 0.700 |
Why?
|
Skull | 6 | 2019 | 254 | 0.690 |
Why?
|
Peripheral Nerve Injuries | 1 | 2019 | 15 | 0.690 |
Why?
|
Nerve Regeneration | 1 | 2019 | 36 | 0.690 |
Why?
|
Endothelial Cells | 3 | 2018 | 455 | 0.670 |
Why?
|
Carcinogenesis | 4 | 2024 | 211 | 0.670 |
Why?
|
Myelin Sheath | 1 | 2019 | 85 | 0.670 |
Why?
|
Bioprinting | 1 | 2019 | 13 | 0.660 |
Why?
|
Real-Time Polymerase Chain Reaction | 10 | 2022 | 282 | 0.630 |
Why?
|
Endothelial Progenitor Cells | 1 | 2018 | 13 | 0.630 |
Why?
|
Simian virus 40 | 2 | 2017 | 35 | 0.630 |
Why?
|
Intervertebral Disc | 7 | 2015 | 16 | 0.620 |
Why?
|
Neoplasms, Experimental | 3 | 2018 | 269 | 0.620 |
Why?
|
Drug Synergism | 13 | 2018 | 305 | 0.620 |
Why?
|
Alkaline Phosphatase | 12 | 2021 | 132 | 0.620 |
Why?
|
Genes, Reporter | 15 | 2017 | 274 | 0.620 |
Why?
|
Chondrocytes | 8 | 2015 | 64 | 0.610 |
Why?
|
Nanoparticles | 4 | 2024 | 164 | 0.610 |
Why?
|
Cell Survival | 17 | 2018 | 981 | 0.610 |
Why?
|
Genetic Therapy | 9 | 2014 | 369 | 0.610 |
Why?
|
Lung Neoplasms | 4 | 2024 | 2344 | 0.600 |
Why?
|
Cell Culture Techniques | 6 | 2019 | 192 | 0.600 |
Why?
|
Cell Cycle | 17 | 2021 | 509 | 0.600 |
Why?
|
Gene Expression Profiling | 12 | 2021 | 1428 | 0.600 |
Why?
|
Phosphoproteins | 3 | 2019 | 260 | 0.600 |
Why?
|
Flavonoids | 2 | 2017 | 87 | 0.590 |
Why?
|
Protein Precursors | 2 | 2017 | 140 | 0.590 |
Why?
|
Phytotherapy | 6 | 2017 | 136 | 0.590 |
Why?
|
Multipotent Stem Cells | 2 | 2014 | 19 | 0.590 |
Why?
|
Biotechnology | 1 | 2017 | 28 | 0.580 |
Why?
|
Retinoid X Receptors | 5 | 2010 | 39 | 0.580 |
Why?
|
Triterpenes | 1 | 2016 | 8 | 0.570 |
Why?
|
Biocompatible Materials | 7 | 2024 | 198 | 0.570 |
Why?
|
Bone Development | 2 | 2008 | 36 | 0.560 |
Why?
|
Founder Effect | 1 | 2017 | 104 | 0.560 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2016 | 16 | 0.560 |
Why?
|
Neovascularization, Physiologic | 5 | 2024 | 142 | 0.560 |
Why?
|
Blotting, Western | 18 | 2018 | 794 | 0.550 |
Why?
|
DNA | 5 | 2014 | 1307 | 0.550 |
Why?
|
DNA Transposable Elements | 2 | 2014 | 174 | 0.550 |
Why?
|
Receptors, Retinoic Acid | 6 | 2012 | 47 | 0.550 |
Why?
|
Recombination, Genetic | 5 | 2014 | 443 | 0.550 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2017 | 125 | 0.540 |
Why?
|
MAP Kinase Signaling System | 3 | 2014 | 197 | 0.540 |
Why?
|
Melanocytes | 2 | 2016 | 57 | 0.540 |
Why?
|
Protein Kinase Inhibitors | 5 | 2024 | 602 | 0.540 |
Why?
|
Transcriptome | 4 | 2022 | 627 | 0.540 |
Why?
|
Colonic Neoplasms | 7 | 2020 | 573 | 0.540 |
Why?
|
Green Fluorescent Proteins | 14 | 2019 | 309 | 0.530 |
Why?
|
Receptors, Erythropoietin | 5 | 1996 | 14 | 0.520 |
Why?
|
Cell Adhesion | 9 | 2019 | 425 | 0.510 |
Why?
|
Odontogenesis | 4 | 2021 | 13 | 0.510 |
Why?
|
Male | 49 | 2024 | 42135 | 0.510 |
Why?
|
Melanoma, Experimental | 4 | 2016 | 104 | 0.500 |
Why?
|
Neoplasm Transplantation | 10 | 2017 | 397 | 0.500 |
Why?
|
HCT116 Cells | 16 | 2019 | 155 | 0.500 |
Why?
|
Neoplasm Invasiveness | 11 | 2018 | 575 | 0.490 |
Why?
|
Adipocytes | 4 | 2019 | 162 | 0.490 |
Why?
|
Flow Cytometry | 7 | 2017 | 690 | 0.490 |
Why?
|
NF-kappa B | 7 | 2024 | 465 | 0.480 |
Why?
|
Stem Cell Transplantation | 5 | 2021 | 188 | 0.480 |
Why?
|
Chondrogenesis | 6 | 2021 | 28 | 0.480 |
Why?
|
Hexadimethrine Bromide | 1 | 2014 | 4 | 0.480 |
Why?
|
Cell Line, Transformed | 7 | 2017 | 155 | 0.480 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2013 | 226 | 0.470 |
Why?
|
Virus Assembly | 1 | 2014 | 21 | 0.470 |
Why?
|
Phenotype | 7 | 2014 | 2439 | 0.470 |
Why?
|
Mice, Inbred BALB C | 8 | 2021 | 1086 | 0.470 |
Why?
|
Immediate-Early Proteins | 2 | 2006 | 165 | 0.470 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 25 | 0.460 |
Why?
|
Fetus | 3 | 2013 | 231 | 0.450 |
Why?
|
Female | 55 | 2024 | 45899 | 0.450 |
Why?
|
Mesoderm | 2 | 2004 | 124 | 0.450 |
Why?
|
Erythropoietin | 6 | 1995 | 88 | 0.440 |
Why?
|
Colitis | 4 | 2022 | 244 | 0.440 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 4 | 2015 | 43 | 0.440 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2024 | 160 | 0.440 |
Why?
|
Recombinant Fusion Proteins | 7 | 2013 | 565 | 0.440 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 666 | 0.430 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2016 | 114 | 0.430 |
Why?
|
Disease Models, Animal | 12 | 2021 | 2347 | 0.430 |
Why?
|
Fracture Healing | 3 | 2017 | 35 | 0.430 |
Why?
|
Niclosamide | 3 | 2018 | 10 | 0.420 |
Why?
|
Janus Kinase 1 | 1 | 2012 | 16 | 0.420 |
Why?
|
Breast Neoplasms | 9 | 2022 | 2991 | 0.420 |
Why?
|
Pyrimidines | 3 | 2024 | 372 | 0.420 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 147 | 0.420 |
Why?
|
Cloning, Organism | 1 | 2012 | 19 | 0.420 |
Why?
|
Growth Hormone | 1 | 2012 | 96 | 0.410 |
Why?
|
Embryo, Mammalian | 6 | 2015 | 221 | 0.410 |
Why?
|
Cell Lineage | 6 | 2013 | 291 | 0.410 |
Why?
|
Mice, Inbred C3H | 7 | 2012 | 371 | 0.410 |
Why?
|
Down-Regulation | 7 | 2020 | 519 | 0.410 |
Why?
|
Wound Healing | 5 | 2022 | 359 | 0.400 |
Why?
|
Intestinal Mucosa | 4 | 2022 | 805 | 0.400 |
Why?
|
Proteolysis | 3 | 2024 | 108 | 0.400 |
Why?
|
Culture Media, Conditioned | 6 | 2016 | 103 | 0.400 |
Why?
|
Piperazines | 2 | 2004 | 283 | 0.400 |
Why?
|
Panax notoginseng | 4 | 2016 | 23 | 0.390 |
Why?
|
Osteoprotegerin | 3 | 2019 | 10 | 0.390 |
Why?
|
Bone Morphogenetic Protein 3 | 3 | 2022 | 6 | 0.390 |
Why?
|
Osteoclasts | 5 | 2020 | 35 | 0.390 |
Why?
|
Pluripotent Stem Cells | 2 | 2009 | 32 | 0.390 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2024 | 267 | 0.380 |
Why?
|
Immunohistochemistry | 11 | 2018 | 1796 | 0.380 |
Why?
|
Benzylisoquinolines | 1 | 2010 | 3 | 0.380 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 54 | 0.380 |
Why?
|
Ovarian Neoplasms | 4 | 2021 | 763 | 0.370 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 177 | 0.370 |
Why?
|
Intestines | 1 | 2014 | 416 | 0.370 |
Why?
|
DNA Primers | 5 | 2022 | 543 | 0.370 |
Why?
|
Acyltransferases | 1 | 2010 | 41 | 0.370 |
Why?
|
Activin Receptors, Type I | 1 | 2010 | 13 | 0.370 |
Why?
|
Bone Diseases | 1 | 2011 | 57 | 0.370 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2021 | 447 | 0.360 |
Why?
|
Integrases | 3 | 2014 | 61 | 0.360 |
Why?
|
Transforming Growth Factor beta | 5 | 2008 | 321 | 0.360 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 4 | 2013 | 23 | 0.360 |
Why?
|
Heterografts | 5 | 2021 | 102 | 0.360 |
Why?
|
Cartilage, Articular | 4 | 2014 | 69 | 0.360 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 2 | 2019 | 29 | 0.350 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2017 | 661 | 0.350 |
Why?
|
Chondrosarcoma | 2 | 2021 | 48 | 0.340 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2017 | 387 | 0.340 |
Why?
|
Mebendazole | 2 | 2021 | 6 | 0.340 |
Why?
|
Antinematodal Agents | 2 | 2021 | 7 | 0.340 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 170 | 0.340 |
Why?
|
Tooth | 2 | 2020 | 51 | 0.340 |
Why?
|
Tumor Cells, Cultured | 12 | 2015 | 1057 | 0.340 |
Why?
|
Myoblasts | 1 | 2009 | 32 | 0.340 |
Why?
|
Osteocytes | 2 | 2012 | 9 | 0.340 |
Why?
|
PPAR gamma | 4 | 2012 | 73 | 0.330 |
Why?
|
Base Sequence | 10 | 2014 | 2326 | 0.330 |
Why?
|
Genes, APC | 2 | 1999 | 27 | 0.330 |
Why?
|
Enzyme Inhibitors | 5 | 2013 | 645 | 0.330 |
Why?
|
Biomarkers | 13 | 2020 | 1753 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2016 | 409 | 0.330 |
Why?
|
Bone Morphogenetic Protein 7 | 4 | 2015 | 13 | 0.330 |
Why?
|
Proto-Oncogene Proteins | 7 | 2003 | 666 | 0.320 |
Why?
|
Transcription, Genetic | 6 | 2013 | 1155 | 0.320 |
Why?
|
X-Ray Microtomography | 5 | 2021 | 89 | 0.320 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2018 | 1938 | 0.320 |
Why?
|
Colon | 3 | 2024 | 509 | 0.320 |
Why?
|
Protein Isoforms | 1 | 2009 | 273 | 0.310 |
Why?
|
Thiazoles | 3 | 2013 | 128 | 0.310 |
Why?
|
Matrix Metalloproteinase 9 | 3 | 2019 | 85 | 0.310 |
Why?
|
Models, Biological | 6 | 2009 | 1763 | 0.310 |
Why?
|
Phosphorylation | 11 | 2018 | 1128 | 0.310 |
Why?
|
Angiotensin II | 2 | 2018 | 93 | 0.300 |
Why?
|
Receptor, Notch1 | 2 | 2019 | 94 | 0.300 |
Why?
|
Nuclear Proteins | 4 | 2016 | 725 | 0.300 |
Why?
|
Calcification, Physiologic | 4 | 2019 | 33 | 0.300 |
Why?
|
Kidney | 8 | 2018 | 1145 | 0.300 |
Why?
|
Enzyme Activation | 8 | 2013 | 698 | 0.300 |
Why?
|
Urine | 2 | 2021 | 89 | 0.300 |
Why?
|
Time Factors | 10 | 2015 | 5313 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2023 | 294 | 0.290 |
Why?
|
Transgenes | 4 | 2019 | 185 | 0.290 |
Why?
|
Durapatite | 3 | 2016 | 28 | 0.290 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 390 | 0.290 |
Why?
|
Magnetite Nanoparticles | 2 | 2018 | 27 | 0.290 |
Why?
|
RNA, Messenger | 17 | 2022 | 2011 | 0.280 |
Why?
|
Promoter Regions, Genetic | 6 | 2014 | 956 | 0.280 |
Why?
|
Mice, Inbred C57BL | 10 | 2024 | 3202 | 0.280 |
Why?
|
Recombinant Proteins | 9 | 2022 | 1011 | 0.280 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2007 | 122 | 0.280 |
Why?
|
Drug Therapy | 1 | 2007 | 70 | 0.280 |
Why?
|
Luciferases | 3 | 2010 | 127 | 0.270 |
Why?
|
Membrane Proteins | 3 | 2021 | 1214 | 0.270 |
Why?
|
Lithium | 2 | 2024 | 59 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 615 | 0.270 |
Why?
|
Homeostasis | 3 | 2022 | 412 | 0.270 |
Why?
|
Bone Matrix | 3 | 2022 | 19 | 0.270 |
Why?
|
Disease | 1 | 2007 | 90 | 0.270 |
Why?
|
Proteome | 2 | 2018 | 132 | 0.270 |
Why?
|
Calcium Phosphates | 2 | 2019 | 77 | 0.270 |
Why?
|
Hypertension | 3 | 2019 | 741 | 0.270 |
Why?
|
Gene Silencing | 6 | 2020 | 178 | 0.270 |
Why?
|
Periodontal Ligament | 2 | 2022 | 3 | 0.270 |
Why?
|
Ultrasonic Therapy | 2 | 2016 | 34 | 0.260 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2021 | 394 | 0.260 |
Why?
|
Smad Proteins | 5 | 2013 | 43 | 0.260 |
Why?
|
ErbB Receptors | 3 | 2018 | 500 | 0.260 |
Why?
|
Fruit | 4 | 2009 | 76 | 0.260 |
Why?
|
Embryonic Stem Cells | 3 | 2014 | 80 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2017 | 126 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2009 | 695 | 0.250 |
Why?
|
Cell Communication | 2 | 2017 | 199 | 0.250 |
Why?
|
PTEN Phosphohydrolase | 3 | 2018 | 136 | 0.250 |
Why?
|
Coculture Techniques | 5 | 2019 | 172 | 0.250 |
Why?
|
Octamer Transcription Factor-2 | 1 | 2024 | 3 | 0.240 |
Why?
|
Dental Papilla | 2 | 2014 | 6 | 0.240 |
Why?
|
Virus Replication | 3 | 2017 | 319 | 0.240 |
Why?
|
Gelatin | 4 | 2017 | 25 | 0.240 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 16 | 0.240 |
Why?
|
Periodontitis | 1 | 2024 | 7 | 0.240 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 7 | 0.240 |
Why?
|
CD11c Antigen | 1 | 2024 | 13 | 0.240 |
Why?
|
Sympathectomy | 2 | 2015 | 17 | 0.240 |
Why?
|
I-kappa B Proteins | 2 | 2005 | 54 | 0.240 |
Why?
|
Thiazolidinediones | 2 | 2018 | 73 | 0.240 |
Why?
|
Gastrointestinal Microbiome | 2 | 2024 | 501 | 0.240 |
Why?
|
Chitosan | 3 | 2019 | 18 | 0.240 |
Why?
|
Face | 2 | 2017 | 116 | 0.240 |
Why?
|
Tetracycline | 1 | 2004 | 13 | 0.240 |
Why?
|
Tooth Germ | 2 | 2021 | 4 | 0.230 |
Why?
|
Morpholines | 1 | 2024 | 69 | 0.230 |
Why?
|
Calcium-Binding Proteins | 4 | 2020 | 121 | 0.230 |
Why?
|
Receptors, Androgen | 1 | 2024 | 122 | 0.230 |
Why?
|
Receptor, IGF Type 1 | 3 | 2023 | 45 | 0.230 |
Why?
|
Random Allocation | 4 | 2017 | 328 | 0.230 |
Why?
|
Hepatitis B Core Antigens | 1 | 2003 | 9 | 0.230 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 458 | 0.230 |
Why?
|
Cell Nucleus | 4 | 2011 | 597 | 0.220 |
Why?
|
Oncogene Proteins, Viral | 1 | 2023 | 34 | 0.220 |
Why?
|
S100 Calcium Binding Protein A6 | 3 | 2015 | 12 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2024 | 311 | 0.220 |
Why?
|
Calgranulin B | 2 | 2013 | 16 | 0.220 |
Why?
|
Mutation | 8 | 2013 | 4121 | 0.220 |
Why?
|
Epidermal Growth Factor | 2 | 2013 | 117 | 0.220 |
Why?
|
CELF1 Protein | 1 | 2022 | 1 | 0.220 |
Why?
|
Hepatitis B | 1 | 2003 | 75 | 0.220 |
Why?
|
Protein Engineering | 1 | 2004 | 141 | 0.210 |
Why?
|
Meningeal Neoplasms | 1 | 2023 | 65 | 0.210 |
Why?
|
Meningioma | 1 | 2023 | 63 | 0.210 |
Why?
|
Caspase 3 | 4 | 2017 | 161 | 0.210 |
Why?
|
Sublingual Gland | 1 | 2022 | 1 | 0.210 |
Why?
|
Obesity | 2 | 2024 | 964 | 0.210 |
Why?
|
Achilles Tendon | 2 | 2016 | 15 | 0.210 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 1767 | 0.210 |
Why?
|
Chromans | 1 | 2002 | 29 | 0.210 |
Why?
|
Glycoproteins | 2 | 2017 | 234 | 0.210 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2019 | 53 | 0.210 |
Why?
|
Blood Group Antigens | 1 | 2022 | 17 | 0.200 |
Why?
|
Gene Knockdown Techniques | 4 | 2021 | 247 | 0.200 |
Why?
|
Antioxidants | 3 | 2018 | 224 | 0.200 |
Why?
|
Fluorescent Antibody Technique | 4 | 2013 | 323 | 0.200 |
Why?
|
High Mobility Group Proteins | 3 | 2007 | 26 | 0.200 |
Why?
|
Biomarkers, Tumor | 6 | 2021 | 1532 | 0.200 |
Why?
|
Cytoplasm | 1 | 2002 | 284 | 0.200 |
Why?
|
Fibrinolysis | 1 | 2022 | 37 | 0.200 |
Why?
|
HeLa Cells | 7 | 2017 | 511 | 0.200 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 146 | 0.200 |
Why?
|
Extracellular Matrix | 5 | 2014 | 244 | 0.200 |
Why?
|
Chemical and Drug Induced Liver Injury, Chronic | 1 | 2021 | 2 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 1095 | 0.190 |
Why?
|
Cisplatin | 2 | 2021 | 617 | 0.190 |
Why?
|
Oxidative Stress | 2 | 2016 | 456 | 0.190 |
Why?
|
Kruppel-Like Factor 6 | 1 | 2021 | 5 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 592 | 0.190 |
Why?
|
Sp1 Transcription Factor | 1 | 2021 | 21 | 0.190 |
Why?
|
Fibrosis | 2 | 2022 | 234 | 0.190 |
Why?
|
Fluorouracil | 3 | 2015 | 561 | 0.190 |
Why?
|
Schwann Cells | 1 | 2021 | 34 | 0.190 |
Why?
|
Photochemotherapy | 1 | 2021 | 100 | 0.190 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 60 | 0.190 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 45 | 0.190 |
Why?
|
Communicable Diseases | 1 | 2021 | 63 | 0.190 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 37 | 0.190 |
Why?
|
Dendritic Cells | 1 | 2024 | 440 | 0.180 |
Why?
|
Polymerase Chain Reaction | 6 | 2017 | 921 | 0.180 |
Why?
|
Extracellular Matrix Proteins | 3 | 2019 | 127 | 0.180 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 33 | 0.180 |
Why?
|
Mesenchymal Stem Cell Transplantation | 4 | 2017 | 61 | 0.180 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2020 | 6 | 0.180 |
Why?
|
NLR Proteins | 1 | 2020 | 2 | 0.180 |
Why?
|
Neural Stem Cells | 1 | 2021 | 58 | 0.180 |
Why?
|
Cell Separation | 4 | 2014 | 198 | 0.180 |
Why?
|
Nomograms | 1 | 2020 | 29 | 0.180 |
Why?
|
Connective Tissue Growth Factor | 2 | 2014 | 15 | 0.180 |
Why?
|
Penile Neoplasms | 1 | 2020 | 17 | 0.180 |
Why?
|
Collagen Type I | 3 | 2019 | 72 | 0.180 |
Why?
|
beta-Arrestin 1 | 1 | 2019 | 4 | 0.180 |
Why?
|
Cell Hypoxia | 2 | 2021 | 170 | 0.180 |
Why?
|
Anticarcinogenic Agents | 2 | 2013 | 73 | 0.180 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2019 | 15 | 0.180 |
Why?
|
Drug Discovery | 2 | 2024 | 107 | 0.180 |
Why?
|
alpha-Fetoproteins | 2 | 2017 | 43 | 0.180 |
Why?
|
Sulindac | 1 | 1999 | 10 | 0.180 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2019 | 172 | 0.170 |
Why?
|
Nanocomposites | 1 | 2019 | 11 | 0.170 |
Why?
|
Organ Culture Techniques | 3 | 2015 | 135 | 0.170 |
Why?
|
Reproducibility of Results | 3 | 2022 | 2750 | 0.170 |
Why?
|
Dentin | 1 | 2019 | 7 | 0.170 |
Why?
|
Rabbits | 7 | 2018 | 637 | 0.170 |
Why?
|
Bone Resorption | 1 | 2019 | 42 | 0.170 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 782 | 0.170 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 461 | 0.170 |
Why?
|
Microscopy, Fluorescence | 4 | 2004 | 428 | 0.170 |
Why?
|
Ultrasonography | 2 | 2019 | 710 | 0.170 |
Why?
|
Rats | 5 | 2019 | 4039 | 0.160 |
Why?
|
Neoplasm Proteins | 5 | 2018 | 540 | 0.160 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2019 | 66 | 0.160 |
Why?
|
Glycogen Synthase Kinase 3 | 3 | 2013 | 69 | 0.160 |
Why?
|
Protein Binding | 4 | 2010 | 1484 | 0.160 |
Why?
|
Intervertebral Disc Degeneration | 2 | 2015 | 7 | 0.160 |
Why?
|
Materials Testing | 2 | 2016 | 93 | 0.160 |
Why?
|
Neurogenesis | 2 | 2010 | 75 | 0.160 |
Why?
|
Liver Neoplasms | 3 | 2015 | 754 | 0.160 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2018 | 237 | 0.160 |
Why?
|
Erlotinib Hydrochloride | 1 | 2018 | 90 | 0.160 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 374 | 0.160 |
Why?
|
Fracture Fixation, Internal | 2 | 2016 | 65 | 0.160 |
Why?
|
Axons | 1 | 2019 | 179 | 0.160 |
Why?
|
Middle Aged | 14 | 2020 | 25787 | 0.160 |
Why?
|
KRIT1 Protein | 1 | 2018 | 62 | 0.160 |
Why?
|
Twist Transcription Factors | 1 | 2018 | 2 | 0.160 |
Why?
|
Genes, myc | 1 | 1998 | 39 | 0.160 |
Why?
|
Glioma | 2 | 2013 | 292 | 0.160 |
Why?
|
Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
Azacitidine | 2 | 2018 | 139 | 0.160 |
Why?
|
Integrin beta3 | 1 | 2018 | 32 | 0.160 |
Why?
|
Myosin Type II | 1 | 2018 | 50 | 0.160 |
Why?
|
Skin Neoplasms | 2 | 2016 | 578 | 0.160 |
Why?
|
Temperature | 2 | 2018 | 400 | 0.160 |
Why?
|
Strontium | 1 | 2018 | 6 | 0.160 |
Why?
|
Cell Membrane Permeability | 1 | 2018 | 119 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2016 | 340 | 0.160 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 502 | 0.160 |
Why?
|
Proteomics | 2 | 2018 | 230 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2009 | 112 | 0.150 |
Why?
|
Motion | 1 | 2018 | 92 | 0.150 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 504 | 0.150 |
Why?
|
HT29 Cells | 5 | 2009 | 50 | 0.150 |
Why?
|
Niacinamide | 1 | 2018 | 115 | 0.150 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2013 | 123 | 0.150 |
Why?
|
B7-H1 Antigen | 1 | 2020 | 272 | 0.150 |
Why?
|
Citric Acid | 1 | 2018 | 38 | 0.150 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 44 | 0.150 |
Why?
|
Molecular Sequence Data | 11 | 2013 | 3026 | 0.150 |
Why?
|
Drug Carriers | 1 | 2018 | 82 | 0.150 |
Why?
|
Chromatography, High Pressure Liquid | 7 | 2018 | 315 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 499 | 0.150 |
Why?
|
Plasmids | 5 | 2018 | 291 | 0.150 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2018 | 66 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2018 | 114 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 287 | 0.150 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 4 | 0.150 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 56 | 0.150 |
Why?
|
Plant Roots | 7 | 2017 | 107 | 0.150 |
Why?
|
Adenovirus E1A Proteins | 1 | 2017 | 7 | 0.150 |
Why?
|
Deoxycytidine | 1 | 2018 | 238 | 0.150 |
Why?
|
Sarcoma | 2 | 2013 | 220 | 0.150 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 112 | 0.150 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2018 | 93 | 0.150 |
Why?
|
Disease Progression | 2 | 2013 | 1483 | 0.150 |
Why?
|
Hand Deformities, Congenital | 1 | 2017 | 15 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 242 | 0.150 |
Why?
|
Transformation, Genetic | 1 | 2017 | 41 | 0.150 |
Why?
|
Dwarfism | 1 | 2017 | 16 | 0.150 |
Why?
|
Eye Proteins | 1 | 2018 | 128 | 0.150 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 50 | 0.150 |
Why?
|
Genitalia, Male | 1 | 2017 | 24 | 0.150 |
Why?
|
Cell Self Renewal | 1 | 2017 | 19 | 0.150 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2018 | 144 | 0.150 |
Why?
|
Phosphates | 1 | 2018 | 160 | 0.150 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 160 | 0.150 |
Why?
|
Osseointegration | 1 | 2017 | 11 | 0.150 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2019 | 96 | 0.140 |
Why?
|
Polyethylene Glycols | 2 | 2017 | 358 | 0.140 |
Why?
|
Pancreas | 1 | 2018 | 244 | 0.140 |
Why?
|
Nylons | 1 | 2016 | 7 | 0.140 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 35 | 0.140 |
Why?
|
Titanium | 1 | 2016 | 20 | 0.140 |
Why?
|
Silver | 1 | 2016 | 16 | 0.140 |
Why?
|
Interleukin-8 | 2 | 2015 | 86 | 0.140 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 20 | 0.140 |
Why?
|
Retroviridae | 1 | 2017 | 79 | 0.140 |
Why?
|
Heat-Shock Proteins | 2 | 2016 | 182 | 0.140 |
Why?
|
Wnt-5a Protein | 1 | 2016 | 10 | 0.140 |
Why?
|
Oncogene Protein v-akt | 2 | 2014 | 21 | 0.140 |
Why?
|
Cadherins | 1 | 2017 | 163 | 0.140 |
Why?
|
Choristoma | 2 | 2013 | 68 | 0.140 |
Why?
|
Immunoenzyme Techniques | 5 | 2012 | 306 | 0.140 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 205 | 0.140 |
Why?
|
Collagen | 2 | 2016 | 293 | 0.140 |
Why?
|
Acrylic Resins | 1 | 2016 | 22 | 0.140 |
Why?
|
Fractures, Malunited | 1 | 2016 | 4 | 0.140 |
Why?
|
Tenocytes | 1 | 2016 | 4 | 0.140 |
Why?
|
Carotid Body | 1 | 2019 | 234 | 0.140 |
Why?
|
Citrates | 1 | 2016 | 28 | 0.140 |
Why?
|
Butyrates | 1 | 2016 | 46 | 0.140 |
Why?
|
Lymph Nodes | 1 | 2020 | 548 | 0.130 |
Why?
|
Coffee | 1 | 2016 | 10 | 0.130 |
Why?
|
Cell Cycle Checkpoints | 2 | 2013 | 66 | 0.130 |
Why?
|
Bone Morphogenetic Protein 6 | 2 | 2007 | 10 | 0.130 |
Why?
|
Cattle | 6 | 2019 | 375 | 0.130 |
Why?
|
Ilium | 1 | 2016 | 18 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 196 | 0.130 |
Why?
|
Osteocalcin | 3 | 2012 | 26 | 0.130 |
Why?
|
Telomerase | 2 | 2013 | 62 | 0.130 |
Why?
|
Humeral Fractures | 1 | 2016 | 17 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2016 | 91 | 0.130 |
Why?
|
Lipids | 2 | 2023 | 271 | 0.130 |
Why?
|
Osteotomy | 1 | 2016 | 33 | 0.130 |
Why?
|
B7-2 Antigen | 1 | 2015 | 40 | 0.130 |
Why?
|
Cytoreduction Surgical Procedures | 1 | 2016 | 76 | 0.130 |
Why?
|
Mice, Knockout | 4 | 2019 | 1990 | 0.130 |
Why?
|
Osteopontin | 3 | 2012 | 47 | 0.130 |
Why?
|
Pelvic Bones | 1 | 2016 | 43 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 57 | 0.130 |
Why?
|
Organoplatinum Compounds | 1 | 2015 | 97 | 0.130 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2018 | 227 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 155 | 0.130 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 75 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2016 | 194 | 0.130 |
Why?
|
DNA Damage | 2 | 2016 | 371 | 0.130 |
Why?
|
RANK Ligand | 2 | 2014 | 10 | 0.130 |
Why?
|
Anthelmintics | 1 | 2015 | 6 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 219 | 0.130 |
Why?
|
Brain Neoplasms | 2 | 2013 | 780 | 0.130 |
Why?
|
Pancreatectomy | 1 | 2016 | 158 | 0.130 |
Why?
|
Transcriptional Activation | 5 | 2018 | 291 | 0.130 |
Why?
|
Hepatitis B virus | 2 | 2006 | 43 | 0.130 |
Why?
|
Binding Sites | 4 | 2007 | 1113 | 0.130 |
Why?
|
Models, Animal | 2 | 2015 | 275 | 0.120 |
Why?
|
Gentian Violet | 2 | 2013 | 10 | 0.120 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.120 |
Why?
|
Adolescent | 8 | 2020 | 9201 | 0.120 |
Why?
|
Structure-Activity Relationship | 3 | 2024 | 411 | 0.120 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 68 | 0.120 |
Why?
|
Tetrazolium Salts | 2 | 2013 | 12 | 0.120 |
Why?
|
Cloning, Molecular | 3 | 2019 | 646 | 0.120 |
Why?
|
Caspases | 2 | 2012 | 155 | 0.120 |
Why?
|
Cell Death | 2 | 2013 | 262 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2024 | 423 | 0.120 |
Why?
|
Hedgehog Proteins | 1 | 2015 | 100 | 0.120 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 108 | 0.120 |
Why?
|
Adenoviridae Infections | 1 | 2014 | 17 | 0.120 |
Why?
|
Twist-Related Protein 1 | 1 | 2014 | 17 | 0.120 |
Why?
|
Cadmium Compounds | 1 | 2014 | 2 | 0.120 |
Why?
|
Selenium Compounds | 1 | 2014 | 3 | 0.120 |
Why?
|
Zinc Compounds | 1 | 2014 | 6 | 0.120 |
Why?
|
Infant | 2 | 2020 | 3130 | 0.120 |
Why?
|
Quantum Dots | 1 | 2014 | 19 | 0.120 |
Why?
|
Liposarcoma, Myxoid | 1 | 2013 | 3 | 0.120 |
Why?
|
Bone Marrow Cells | 2 | 2012 | 262 | 0.120 |
Why?
|
S100 Calcium-Binding Protein A4 | 1 | 2013 | 4 | 0.120 |
Why?
|
Blood Pressure | 2 | 2015 | 898 | 0.120 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 363 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 243 | 0.120 |
Why?
|
Sarcoma, Synovial | 1 | 2013 | 21 | 0.120 |
Why?
|
Luminescent Proteins | 4 | 2003 | 144 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 434 | 0.110 |
Why?
|
Sulfides | 1 | 2014 | 68 | 0.110 |
Why?
|
Alzheimer Disease | 1 | 2018 | 481 | 0.110 |
Why?
|
Lasers | 1 | 2014 | 107 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2016 | 688 | 0.110 |
Why?
|
Primary Cell Culture | 3 | 2020 | 76 | 0.110 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2013 | 137 | 0.110 |
Why?
|
Artemisinins | 1 | 2013 | 5 | 0.110 |
Why?
|
Subrenal Capsule Assay | 1 | 2013 | 5 | 0.110 |
Why?
|
Mammals | 3 | 2022 | 235 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2007 | 1194 | 0.110 |
Why?
|
Genistein | 1 | 2013 | 16 | 0.110 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2013 | 5 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1993 | 80 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2013 | 7 | 0.110 |
Why?
|
Imatinib Mesylate | 2 | 2004 | 127 | 0.110 |
Why?
|
Receptor Cross-Talk | 1 | 2013 | 34 | 0.110 |
Why?
|
Luciferases, Firefly | 2 | 2012 | 12 | 0.110 |
Why?
|
Calgranulin A | 1 | 2013 | 11 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 145 | 0.110 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 55 | 0.110 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 1241 | 0.110 |
Why?
|
Estradiol | 1 | 2013 | 250 | 0.110 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 114 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 167 | 0.110 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 281 | 0.110 |
Why?
|
Estrogens | 1 | 2013 | 201 | 0.110 |
Why?
|
Transplantation, Heterologous | 2 | 2011 | 370 | 0.110 |
Why?
|
Benzamides | 2 | 2004 | 237 | 0.110 |
Why?
|
PAX3 Transcription Factor | 1 | 2012 | 11 | 0.100 |
Why?
|
Hot Temperature | 3 | 2009 | 208 | 0.100 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2012 | 43 | 0.100 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2012 | 14 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 634 | 0.100 |
Why?
|
Adenomatous Polyposis Coli Protein | 4 | 2000 | 41 | 0.100 |
Why?
|
Smad4 Protein | 2 | 2019 | 24 | 0.100 |
Why?
|
Amino Acid Sequence | 7 | 2013 | 2061 | 0.100 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 52 | 0.100 |
Why?
|
Electromagnetic Fields | 1 | 2012 | 26 | 0.100 |
Why?
|
Pregnancy Proteins | 1 | 2012 | 38 | 0.100 |
Why?
|
Appetite | 1 | 2012 | 26 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 89 | 0.100 |
Why?
|
Catechin | 1 | 2012 | 24 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2012 | 80 | 0.100 |
Why?
|
Perfusion | 1 | 2013 | 234 | 0.100 |
Why?
|
Viral Core Proteins | 1 | 2011 | 28 | 0.100 |
Why?
|
Urology | 1 | 2013 | 117 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2012 | 122 | 0.100 |
Why?
|
Malonates | 1 | 2011 | 11 | 0.100 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 255 | 0.100 |
Why?
|
Collagen Type II | 2 | 2009 | 14 | 0.100 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 198 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 197 | 0.100 |
Why?
|
Sirtuins | 1 | 2011 | 46 | 0.100 |
Why?
|
Interferon Type I | 1 | 2012 | 178 | 0.100 |
Why?
|
Immunotherapy | 3 | 2024 | 664 | 0.100 |
Why?
|
TCF Transcription Factors | 3 | 2000 | 24 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 3 | 2000 | 29 | 0.090 |
Why?
|
Camptothecin | 1 | 2012 | 193 | 0.090 |
Why?
|
Extremities | 3 | 2013 | 168 | 0.090 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2010 | 33 | 0.090 |
Why?
|
Hep G2 Cells | 3 | 2021 | 48 | 0.090 |
Why?
|
Lysine | 1 | 2011 | 150 | 0.090 |
Why?
|
Hepacivirus | 1 | 2011 | 129 | 0.090 |
Why?
|
Activin Receptors, Type II | 1 | 2010 | 9 | 0.090 |
Why?
|
3' Untranslated Regions | 2 | 2022 | 94 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 185 | 0.090 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2010 | 3 | 0.090 |
Why?
|
Janus Kinase 2 | 6 | 1996 | 60 | 0.090 |
Why?
|
Growth and Development | 1 | 2010 | 12 | 0.090 |
Why?
|
Adult | 11 | 2016 | 26439 | 0.090 |
Why?
|
RNA | 2 | 2004 | 578 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2013 | 420 | 0.090 |
Why?
|
Dental Pulp | 2 | 2020 | 4 | 0.090 |
Why?
|
Corydalis | 1 | 2009 | 4 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 2013 | 0.090 |
Why?
|
Heart | 1 | 2013 | 573 | 0.090 |
Why?
|
Reactive Oxygen Species | 4 | 2016 | 487 | 0.090 |
Why?
|
Carrier Proteins | 1 | 2013 | 680 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 1062 | 0.090 |
Why?
|
Tyrosine Transaminase | 3 | 2015 | 3 | 0.080 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2009 | 17 | 0.080 |
Why?
|
Wnt1 Protein | 2 | 2013 | 25 | 0.080 |
Why?
|
Antigens, Differentiation | 3 | 2016 | 141 | 0.080 |
Why?
|
Osteoblastoma | 1 | 2009 | 4 | 0.080 |
Why?
|
Aggrecans | 1 | 2009 | 43 | 0.080 |
Why?
|
Chemoprevention | 2 | 2013 | 92 | 0.080 |
Why?
|
Oncolytic Viruses | 1 | 2009 | 24 | 0.080 |
Why?
|
Drug Repositioning | 2 | 2021 | 22 | 0.080 |
Why?
|
Wnt3 Protein | 2 | 2009 | 14 | 0.080 |
Why?
|
Cyclosporine | 1 | 2010 | 237 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 beta | 3 | 2013 | 44 | 0.080 |
Why?
|
Keratinocytes | 1 | 2010 | 145 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 381 | 0.080 |
Why?
|
Protein Stability | 3 | 2014 | 100 | 0.080 |
Why?
|
Oncolytic Virotherapy | 1 | 2009 | 42 | 0.080 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2008 | 7 | 0.080 |
Why?
|
RecQ Helicases | 1 | 2008 | 7 | 0.080 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2021 | 67 | 0.080 |
Why?
|
Neurofibromatosis 2 | 1 | 2008 | 11 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 161 | 0.080 |
Why?
|
Escherichia coli | 3 | 2016 | 605 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2019 | 199 | 0.080 |
Why?
|
Proto-Oncogenes | 1 | 2008 | 61 | 0.080 |
Why?
|
Precision Medicine | 1 | 2012 | 408 | 0.080 |
Why?
|
Models, Statistical | 1 | 2012 | 575 | 0.080 |
Why?
|
Retinoblastoma Protein | 1 | 2008 | 67 | 0.080 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2007 | 7 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 184 | 0.080 |
Why?
|
Histones | 2 | 2024 | 329 | 0.080 |
Why?
|
Neurons | 2 | 2021 | 1576 | 0.070 |
Why?
|
Microspheres | 2 | 2019 | 108 | 0.070 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2007 | 25 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 63 | 0.070 |
Why?
|
Survival Rate | 3 | 2015 | 1881 | 0.070 |
Why?
|
In Vitro Techniques | 2 | 2019 | 996 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 1146 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 2550 | 0.070 |
Why?
|
NF-KappaB Inhibitor alpha | 2 | 2005 | 42 | 0.070 |
Why?
|
Retinoic Acid Receptor alpha | 3 | 2012 | 18 | 0.070 |
Why?
|
Odontoblasts | 2 | 2019 | 9 | 0.070 |
Why?
|
Tensile Strength | 1 | 2007 | 80 | 0.070 |
Why?
|
SOX9 Transcription Factor | 4 | 2009 | 26 | 0.070 |
Why?
|
Indocyanine Green | 2 | 2019 | 22 | 0.070 |
Why?
|
Child | 5 | 2019 | 7113 | 0.070 |
Why?
|
Nestin | 2 | 2021 | 18 | 0.070 |
Why?
|
Interleukin-3 | 3 | 1995 | 36 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2023 | 451 | 0.070 |
Why?
|
Genetic Techniques | 1 | 2007 | 73 | 0.070 |
Why?
|
Growth Substances | 1 | 2006 | 80 | 0.070 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2006 | 5 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2006 | 52 | 0.070 |
Why?
|
Proteins | 2 | 2004 | 786 | 0.070 |
Why?
|
Child, Preschool | 3 | 2019 | 3695 | 0.070 |
Why?
|
DNA Fingerprinting | 1 | 2005 | 16 | 0.070 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 136 | 0.070 |
Why?
|
Hypertrophy | 2 | 2019 | 67 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2021 | 1989 | 0.070 |
Why?
|
Dextran Sulfate | 2 | 2017 | 68 | 0.070 |
Why?
|
Azoxymethane | 2 | 2017 | 84 | 0.060 |
Why?
|
Mitogens | 2 | 1996 | 62 | 0.060 |
Why?
|
Nucleocapsid Proteins | 1 | 2005 | 10 | 0.060 |
Why?
|
Spinal Diseases | 1 | 2005 | 44 | 0.060 |
Why?
|
Mutagenesis | 3 | 1994 | 202 | 0.060 |
Why?
|
DNA Mutational Analysis | 3 | 2002 | 529 | 0.060 |
Why?
|
Cyclins | 3 | 2008 | 83 | 0.060 |
Why?
|
Salmonella Infections | 1 | 2005 | 18 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 3757 | 0.060 |
Why?
|
Salmonella typhimurium | 1 | 2005 | 32 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2024 | 9 | 0.060 |
Why?
|
Antigens, Viral | 1 | 2005 | 145 | 0.060 |
Why?
|
Spinal Fusion | 1 | 2005 | 86 | 0.060 |
Why?
|
Cytomegalovirus | 1 | 2005 | 76 | 0.060 |
Why?
|
Tendons | 1 | 2005 | 44 | 0.060 |
Why?
|
Hydrazones | 1 | 2024 | 7 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 975 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 2 | 2021 | 37 | 0.060 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1995 | 112 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2018 | 104 | 0.060 |
Why?
|
Particle Size | 1 | 2024 | 124 | 0.060 |
Why?
|
Hyperphagia | 1 | 2024 | 36 | 0.060 |
Why?
|
Injections | 1 | 2024 | 115 | 0.060 |
Why?
|
Image Enhancement | 1 | 2007 | 567 | 0.060 |
Why?
|
Cytomegalovirus Infections | 1 | 2005 | 146 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2024 | 106 | 0.060 |
Why?
|
T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2023 | 4 | 0.060 |
Why?
|
Glycogen | 2 | 2014 | 59 | 0.060 |
Why?
|
Genes, MHC Class I | 1 | 2023 | 48 | 0.060 |
Why?
|
Colonic Polyps | 1 | 2005 | 132 | 0.060 |
Why?
|
Drug Design | 1 | 2004 | 124 | 0.060 |
Why?
|
Glutamic Acid | 1 | 2024 | 154 | 0.060 |
Why?
|
Keratin-18 | 2 | 2015 | 3 | 0.060 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2023 | 31 | 0.060 |
Why?
|
Constriction | 1 | 2023 | 27 | 0.060 |
Why?
|
Thymocytes | 1 | 2023 | 31 | 0.060 |
Why?
|
Safety | 1 | 2004 | 149 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2003 | 73 | 0.060 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2023 | 31 | 0.060 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 57 | 0.060 |
Why?
|
Cyclooxygenase 2 | 2 | 2013 | 99 | 0.060 |
Why?
|
Intervertebral Disc Displacement | 1 | 2003 | 22 | 0.060 |
Why?
|
Human papillomavirus 16 | 1 | 2023 | 38 | 0.060 |
Why?
|
Aged | 7 | 2020 | 19019 | 0.050 |
Why?
|
Proteoglycans | 2 | 2018 | 123 | 0.050 |
Why?
|
Kinetics | 3 | 1994 | 1527 | 0.050 |
Why?
|
Fluid Therapy | 1 | 2023 | 51 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 170 | 0.050 |
Why?
|
DNA Methylation | 2 | 2020 | 657 | 0.050 |
Why?
|
Vaccines | 1 | 2004 | 82 | 0.050 |
Why?
|
Goals | 1 | 2023 | 67 | 0.050 |
Why?
|
Bacteria | 1 | 2007 | 471 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2003 | 133 | 0.050 |
Why?
|
Adenoma | 1 | 2005 | 246 | 0.050 |
Why?
|
Androgens | 1 | 2023 | 175 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 200 | 0.050 |
Why?
|
Salivary Glands | 1 | 2022 | 18 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2002 | 67 | 0.050 |
Why?
|
Cyclin D1 | 1 | 2002 | 84 | 0.050 |
Why?
|
Cell Transplantation | 2 | 2015 | 47 | 0.050 |
Why?
|
Androgen Antagonists | 1 | 2023 | 154 | 0.050 |
Why?
|
G1 Phase | 2 | 2012 | 65 | 0.050 |
Why?
|
Fibrinolysin | 1 | 2022 | 26 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2002 | 88 | 0.050 |
Why?
|
Bone Density | 1 | 2003 | 209 | 0.050 |
Why?
|
Filgrastim | 1 | 2022 | 57 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 125 | 0.050 |
Why?
|
Dogs | 2 | 2013 | 704 | 0.050 |
Why?
|
Survival Analysis | 1 | 2005 | 1533 | 0.050 |
Why?
|
Vacuoles | 2 | 2013 | 46 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2016 | 8963 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 268 | 0.050 |
Why?
|
Cell Shape | 2 | 2016 | 51 | 0.050 |
Why?
|
Low-Level Light Therapy | 1 | 2021 | 15 | 0.050 |
Why?
|
MCF-7 Cells | 1 | 2022 | 114 | 0.050 |
Why?
|
Photosensitizing Agents | 1 | 2021 | 50 | 0.050 |
Why?
|
Retinoid X Receptor alpha | 2 | 2012 | 7 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 166 | 0.050 |
Why?
|
Swine | 1 | 2022 | 581 | 0.050 |
Why?
|
Exosomes | 1 | 2022 | 53 | 0.050 |
Why?
|
Karyopherins | 1 | 2020 | 15 | 0.050 |
Why?
|
Microarray Analysis | 2 | 2013 | 96 | 0.050 |
Why?
|
Exons | 1 | 2002 | 451 | 0.050 |
Why?
|
Mitochondria | 2 | 2016 | 551 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2015 | 8178 | 0.050 |
Why?
|
Stroke Volume | 1 | 2023 | 461 | 0.050 |
Why?
|
Tooth Exfoliation | 1 | 2020 | 2 | 0.050 |
Why?
|
Tooth, Deciduous | 1 | 2020 | 3 | 0.050 |
Why?
|
Pyridines | 2 | 2013 | 315 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 129 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2022 | 263 | 0.050 |
Why?
|
Chromatin | 1 | 2023 | 397 | 0.040 |
Why?
|
Oleic Acid | 1 | 2019 | 15 | 0.040 |
Why?
|
SEER Program | 1 | 2020 | 197 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2021 | 372 | 0.040 |
Why?
|
Risk Factors | 3 | 2019 | 5448 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2018 | 2464 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 699 | 0.040 |
Why?
|
Dentinogenesis Imperfecta | 1 | 2019 | 2 | 0.040 |
Why?
|
Ameloblasts | 1 | 2019 | 2 | 0.040 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2019 | 93 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2022 | 257 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2019 | 47 | 0.040 |
Why?
|
Chondroitin Sulfates | 1 | 2019 | 43 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 2019 | 31 | 0.040 |
Why?
|
Databases, Factual | 1 | 2023 | 849 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 2019 | 87 | 0.040 |
Why?
|
Triglycerides | 1 | 2019 | 232 | 0.040 |
Why?
|
Fatty Liver | 1 | 2019 | 95 | 0.040 |
Why?
|
Incidence | 1 | 2023 | 1591 | 0.040 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2018 | 4 | 0.040 |
Why?
|
Transposon Resolvases | 1 | 2018 | 7 | 0.040 |
Why?
|
Magnetic Fields | 1 | 2018 | 11 | 0.040 |
Why?
|
Drug Liberation | 1 | 2018 | 16 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2018 | 123 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 78 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2018 | 5 | 0.040 |
Why?
|
Quinoxalines | 1 | 2018 | 50 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 858 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 848 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 307 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2018 | 8 | 0.040 |
Why?
|
Computational Biology | 1 | 2021 | 542 | 0.040 |
Why?
|
Exonucleases | 1 | 1997 | 8 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2015 | 392 | 0.040 |
Why?
|
Liver Failure | 1 | 2018 | 67 | 0.040 |
Why?
|
G2 Phase | 1 | 1997 | 34 | 0.040 |
Why?
|
Periodic Acid | 1 | 2017 | 4 | 0.040 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1997 | 44 | 0.040 |
Why?
|
Young Adult | 3 | 2016 | 6271 | 0.040 |
Why?
|
Flowers | 2 | 2009 | 37 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 135 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2024 | 1222 | 0.040 |
Why?
|
Silicates | 1 | 2017 | 4 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2017 | 34 | 0.040 |
Why?
|
Genomics | 1 | 2023 | 751 | 0.040 |
Why?
|
Graphite | 1 | 2017 | 12 | 0.040 |
Why?
|
Mitosis | 1 | 1997 | 152 | 0.040 |
Why?
|
Liver Regeneration | 1 | 2017 | 36 | 0.040 |
Why?
|
Pandemics | 1 | 2023 | 770 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2017 | 75 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2017 | 168 | 0.040 |
Why?
|
Virion | 1 | 2017 | 59 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 217 | 0.040 |
Why?
|
Isoenzymes | 1 | 1997 | 273 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 374 | 0.040 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2016 | 8 | 0.040 |
Why?
|
Osteomyelitis | 1 | 2016 | 54 | 0.040 |
Why?
|
Antiparasitic Agents | 1 | 2016 | 8 | 0.040 |
Why?
|
Albumins | 1 | 2017 | 129 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2017 | 117 | 0.030 |
Why?
|
Actin Cytoskeleton | 1 | 2018 | 196 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1996 | 67 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2016 | 65 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 43 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2018 | 901 | 0.030 |
Why?
|
Bone Plates | 1 | 2016 | 23 | 0.030 |
Why?
|
Ovariectomy | 1 | 2016 | 81 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2016 | 20 | 0.030 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2016 | 32 | 0.030 |
Why?
|
Oncogenes | 1 | 1996 | 92 | 0.030 |
Why?
|
Cartilage | 1 | 2016 | 116 | 0.030 |
Why?
|
Genes, p53 | 1 | 1996 | 109 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 109 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 2015 | 27 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2016 | 118 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 1236 | 0.030 |
Why?
|
Low Back Pain | 1 | 2016 | 41 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2015 | 27 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 36 | 0.030 |
Why?
|
Antigens, CD | 1 | 2017 | 466 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2015 | 7 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 115 | 0.030 |
Why?
|
Frontal Bone | 1 | 2015 | 16 | 0.030 |
Why?
|
Comorbidity | 1 | 2019 | 947 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2016 | 154 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 1999 | 555 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1995 | 33 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2018 | 259 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 45 | 0.030 |
Why?
|
Smoking | 1 | 2019 | 620 | 0.030 |
Why?
|
Gossypol | 1 | 2014 | 6 | 0.030 |
Why?
|
Hysterectomy | 1 | 2016 | 150 | 0.030 |
Why?
|
Tyrosine | 1 | 1995 | 133 | 0.030 |
Why?
|
Growth Inhibitors | 2 | 2009 | 42 | 0.030 |
Why?
|
Inflammation | 1 | 2020 | 969 | 0.030 |
Why?
|
Shoulder Joint | 1 | 2016 | 91 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 181 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2016 | 207 | 0.030 |
Why?
|
Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.030 |
Why?
|
Dependovirus | 1 | 2014 | 33 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2014 | 10 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2014 | 39 | 0.030 |
Why?
|
Antigens, Viral, Tumor | 1 | 2014 | 15 | 0.030 |
Why?
|
Sequestosome-1 Protein | 1 | 2014 | 22 | 0.030 |
Why?
|
Allografts | 1 | 2015 | 178 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 991 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 2 | 2009 | 159 | 0.030 |
Why?
|
Cytokines | 1 | 2018 | 801 | 0.030 |
Why?
|
Absorption, Radiation | 1 | 2014 | 4 | 0.030 |
Why?
|
Risk | 1 | 2016 | 657 | 0.030 |
Why?
|
DNA Repair | 1 | 2016 | 361 | 0.030 |
Why?
|
Acetylation | 1 | 2014 | 132 | 0.030 |
Why?
|
Maleimides | 1 | 2013 | 26 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2014 | 116 | 0.030 |
Why?
|
Baculoviridae | 1 | 1993 | 34 | 0.030 |
Why?
|
Glucuronosyltransferase | 1 | 2015 | 186 | 0.030 |
Why?
|
Homologous Recombination | 1 | 2014 | 52 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1993 | 156 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 89 | 0.030 |
Why?
|
Photons | 1 | 2014 | 47 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2015 | 524 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2013 | 8 | 0.030 |
Why?
|
Molecular Weight | 1 | 1993 | 331 | 0.030 |
Why?
|
Trypan Blue | 1 | 2013 | 3 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 86 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2016 | 275 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 87 | 0.030 |
Why?
|
Saponins | 1 | 2013 | 42 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 2013 | 35 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1993 | 177 | 0.030 |
Why?
|
Moths | 1 | 1993 | 31 | 0.030 |
Why?
|
Antimalarials | 1 | 2013 | 20 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2013 | 11 | 0.030 |
Why?
|
Isoflavones | 1 | 2013 | 13 | 0.030 |
Why?
|
Cytosol | 1 | 1993 | 192 | 0.030 |
Why?
|
G2 Phase Cell Cycle Checkpoints | 1 | 2013 | 12 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 179 | 0.030 |
Why?
|
Clone Cells | 1 | 2013 | 214 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2016 | 315 | 0.030 |
Why?
|
Polyesters | 1 | 2013 | 41 | 0.030 |
Why?
|
Epitopes | 1 | 1993 | 255 | 0.030 |
Why?
|
rho GTP-Binding Proteins | 1 | 2013 | 55 | 0.030 |
Why?
|
Exome | 1 | 2013 | 127 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2013 | 85 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2014 | 225 | 0.030 |
Why?
|
Renal Circulation | 1 | 2013 | 48 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 92 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 86 | 0.030 |
Why?
|
Lactic Acid | 1 | 2013 | 92 | 0.030 |
Why?
|
Aging | 1 | 2018 | 713 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2013 | 30 | 0.030 |
Why?
|
Regeneration | 1 | 2014 | 149 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 79 | 0.030 |
Why?
|
Renal Artery | 1 | 2013 | 52 | 0.030 |
Why?
|
Resting Phase, Cell Cycle | 1 | 2012 | 5 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2013 | 85 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2023 | 2273 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2013 | 198 | 0.030 |
Why?
|
Equipment Design | 1 | 2014 | 415 | 0.030 |
Why?
|
Annexin A5 | 1 | 2012 | 20 | 0.030 |
Why?
|
Receptor, ErbB-2 | 1 | 2014 | 238 | 0.030 |
Why?
|
Injections, Intraventricular | 1 | 2012 | 19 | 0.030 |
Why?
|
Telomere | 1 | 2013 | 114 | 0.030 |
Why?
|
Caspase 9 | 1 | 2012 | 49 | 0.030 |
Why?
|
Molecular Docking Simulation | 1 | 2012 | 48 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 71 | 0.030 |
Why?
|
Imidazoles | 1 | 2013 | 148 | 0.030 |
Why?
|
Polymers | 1 | 2013 | 194 | 0.030 |
Why?
|
Phosphoglycerate Kinase | 1 | 2011 | 17 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 285 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2011 | 41 | 0.020 |
Why?
|
Succinates | 1 | 2011 | 21 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 312 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 740 | 0.020 |
Why?
|
Catheterization | 1 | 2013 | 237 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2011 | 78 | 0.020 |
Why?
|
Dexamethasone | 1 | 2013 | 344 | 0.020 |
Why?
|
Graft Survival | 1 | 2015 | 895 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2011 | 130 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2012 | 313 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 2013 | 234 | 0.020 |
Why?
|
Cell Membrane | 1 | 1994 | 668 | 0.020 |
Why?
|
Horses | 1 | 2011 | 35 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2016 | 1849 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2010 | 40 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 4 | 1 | 2010 | 4 | 0.020 |
Why?
|
Caspase Inhibitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Serum | 1 | 2011 | 25 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 21 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 53 | 0.020 |
Why?
|
Implants, Experimental | 1 | 2010 | 16 | 0.020 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 59 | 0.020 |
Why?
|
Retinoid X Receptor gamma | 1 | 2010 | 1 | 0.020 |
Why?
|
Retinoid X Receptor beta | 1 | 2010 | 1 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2013 | 778 | 0.020 |
Why?
|
Acetylcysteine | 1 | 2010 | 70 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2010 | 35 | 0.020 |
Why?
|
Oligopeptides | 1 | 2011 | 188 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 183 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 23 | 0.020 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2009 | 24 | 0.020 |
Why?
|
Plants, Medicinal | 1 | 2009 | 42 | 0.020 |
Why?
|
Heart Failure | 1 | 2019 | 1172 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 1354 | 0.020 |
Why?
|
Collagen Type X | 1 | 2009 | 2 | 0.020 |
Why?
|
Antibodies | 1 | 2011 | 353 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2011 | 461 | 0.020 |
Why?
|
Ceruloplasmin | 1 | 2009 | 8 | 0.020 |
Why?
|
Graft Rejection | 1 | 2015 | 1061 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 866 | 0.020 |
Why?
|
Eye Abnormalities | 1 | 2009 | 41 | 0.020 |
Why?
|
bcl-Associated Death Protein | 1 | 2009 | 16 | 0.020 |
Why?
|
Rhizome | 1 | 2009 | 6 | 0.020 |
Why?
|
Beclin-1 | 1 | 2009 | 15 | 0.020 |
Why?
|
Neprilysin | 1 | 2009 | 41 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 442 | 0.020 |
Why?
|
Cohort Studies | 1 | 2016 | 2855 | 0.020 |
Why?
|
Heating | 1 | 2008 | 14 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2010 | 436 | 0.020 |
Why?
|
Humerus | 1 | 2008 | 31 | 0.020 |
Why?
|
Femoral Neoplasms | 1 | 2008 | 23 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2015 | 3649 | 0.020 |
Why?
|
Joints | 1 | 2008 | 32 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2013 | 6758 | 0.020 |
Why?
|
Polymethyl Methacrylate | 1 | 2007 | 13 | 0.020 |
Why?
|
Cyclin A | 1 | 2007 | 29 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 258 | 0.020 |
Why?
|
Brain | 1 | 2018 | 2269 | 0.020 |
Why?
|
Fibrosarcoma | 1 | 2007 | 85 | 0.020 |
Why?
|
Autophagy | 1 | 2009 | 154 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2008 | 371 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 511 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1997 | 80 | 0.020 |
Why?
|
Molecular Structure | 1 | 2006 | 288 | 0.020 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2005 | 8 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2005 | 5 | 0.020 |
Why?
|
Calcium | 1 | 2010 | 1171 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2009 | 1573 | 0.020 |
Why?
|
Luminescent Agents | 1 | 2005 | 6 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 448 | 0.020 |
Why?
|
fas Receptor | 1 | 2005 | 77 | 0.020 |
Why?
|
Tendon Injuries | 1 | 2005 | 36 | 0.020 |
Why?
|
Hyperplasia | 1 | 2005 | 152 | 0.020 |
Why?
|
DNA, Viral | 1 | 2005 | 261 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 2331 | 0.010 |
Why?
|
Desmin | 1 | 2003 | 10 | 0.010 |
Why?
|
Myoglobin | 1 | 2003 | 29 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 2003 | 19 | 0.010 |
Why?
|
Lymphocytes | 1 | 2005 | 471 | 0.010 |
Why?
|
Actins | 1 | 2003 | 458 | 0.010 |
Why?
|
CDX2 Transcription Factor | 1 | 1999 | 7 | 0.010 |
Why?
|
Algorithms | 1 | 2007 | 1870 | 0.010 |
Why?
|
Exoribonucleases | 1 | 1997 | 9 | 0.010 |
Why?
|
Polyploidy | 1 | 1997 | 18 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 1997 | 10 | 0.010 |
Why?
|
Eukaryotic Cells | 1 | 1997 | 44 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 354 | 0.010 |
Why?
|
Cell Fusion | 1 | 1996 | 39 | 0.010 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 1996 | 23 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1996 | 73 | 0.010 |
Why?
|
Alleles | 1 | 1999 | 1135 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 418 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 283 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 1996 | 198 | 0.010 |
Why?
|
United States | 1 | 2008 | 6931 | 0.010 |
Why?
|
Point Mutation | 1 | 1996 | 245 | 0.010 |
Why?
|
Reading Frames | 1 | 1994 | 6 | 0.010 |
Why?
|
Terminator Regions, Genetic | 1 | 1994 | 14 | 0.010 |
Why?
|
Receptors, Interleukin-3 | 1 | 1994 | 3 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 127 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1994 | 205 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1997 | 839 | 0.010 |
Why?
|